New Hampshire biologics regulations.

Who may administer PRP, exosomes and stem cells in New Hampshire, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in New Hampshire?

In New Hampshire, only licensed healthcare professionals—such as physicians with an MD or DO are legally qualified to administer biologic therapies like stem cell injections.

Official sources

New Hampshire compliance guide.

FDA Compliance

Providers offering biologic therapies must comply with federal regulations set by the U.S. Food and Drug Administration (FDA). Most biologics fall under the guidelines for Human Cells, Tissues, and Cellular and Tissue-Based Products (FDA HCT/P). Clinics should verify that their therapies align with FDA regulations, which are primarily detailed under 21 CFR Part 1271. Familiarity with these requirements is crucial to ensuring lawful practices.

State Regulations

New Hampshire’s Department of Health and Human Services oversees health regulations, which include guidelines on advanced medical treatments. Though New Hampshire may not have specific stem cell regulations, providers should review applicable state healthcare laws and requirements. For additional information, consult the New Hampshire Department of Health and Human Services. This step is key to ensuring both federal and state compliance.

Provider Qualifications

In New Hampshire, only licensed healthcare professionals—such as physicians with an MD or DO are legally qualified to administer biologic therapies like stem cell injections. Credential requirements vary, and it is advisable to consult the New Hampshire Office of Professional Licensure and Certification for specific licensing requirements.

Patient Informed Consent

Ensuring patients are fully informed is vital to regulatory compliance. Consent forms should outline the benefits, risks, and potential outcomes of the therapy. It is also essential to include disclaimers regarding the experimental nature of many biologic treatments. The FDA's clinical trial guidelines provide insights into informed consent best practices for novel therapies.

Pre-Treatment and Post-Treatment Protocols

Comprehensive protocols for pre-treatment assessment and post-treatment follow-up help maintain clinical consistency and patient safety. Establishing and adhering to Standard Operating Procedures (SOPs) for these protocols can streamline processes and enhance regulatory adherence.

Medical Liability Insurance

It is essential for clinics to carry medical liability insurance tailored to biologic treatments. Providers should work with an insurance specialist to ensure coverage aligns with both federal and New Hampshire state requirements.

Marketing Compliance

Marketing materials must avoid overstatement of treatment efficacy and adhere to FDA and FTC guidelines. Ensure all claims are accurate and that any reference to biologics clearly states the experimental nature, if applicable. Refer to the FDA’s guidance on health fraud prevention for marketing integrity.

This guide is a general summary to help clinics understand compliance requirements for biologics in New Hampshire. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

New Hampshire: common questions.

Who can administer stem cells, PRP and exosomes in New Hampshire?
In New Hampshire, only licensed healthcare professionals—such as physicians with an MD or DO are legally qualified to administer biologic therapies like stem cell injections. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in New Hampshire?
FDA rules are federal, so they apply in New Hampshire as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in New Hampshire?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in New Hampshire?
Start with the live webinar, then a discovery call and live training. After that we verify your New Hampshire licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in New Hampshire? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.